Diabetic macular oedema and role of intra viteral triamcinolone acetonide

ABSTRACT

The aim of this study was to determine efficiency of intravitreal injection of triamcinolone [IVT] in diffuse macular edema secondary to diabetes mellitus. Twenty eight eyes of 28 patients who fulfilled the inclusion criteria were selected for the study. Patients had a full ophthalmic examination carried out. Injection triamcinolone acetonide [Kenalog] was given intravitreally with full aseptic measures patients were followed up at selected intervals of time. At one month post injection interval 54% patients showed improvement in visual acuity. Three months post injection 43% patients maintained improvement in visual acuity. At six months post injections 18% maintained improvement while 43% showed no change and 14% showed deterioration of vision. We conclude that IVT has a favorable outcome in significant number of patients and may be an alternative to laser photocoagulation in diffuse macular edema secondary to diabetes mellitus